Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer
Jingqiang Huang(Shenzhen University), Li-Yun Gong(Shenzhen University)
Cited by 24
Related Papers
SOX9 drives the epithelial–mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway
|Journal of Translational Medicine|2019|139
SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer
|Journal of Translational Medicine|2021|49